ATE269896T1 - Unterdrückung der abstossung bei xenotransplantation - Google Patents
Unterdrückung der abstossung bei xenotransplantationInfo
- Publication number
- ATE269896T1 ATE269896T1 AT99956179T AT99956179T ATE269896T1 AT E269896 T1 ATE269896 T1 AT E269896T1 AT 99956179 T AT99956179 T AT 99956179T AT 99956179 T AT99956179 T AT 99956179T AT E269896 T1 ATE269896 T1 AT E269896T1
- Authority
- AT
- Austria
- Prior art keywords
- suppression
- rejection
- xenotransplantation
- relates
- cells
- Prior art date
Links
- 230000001629 suppression Effects 0.000 title abstract 3
- 238000002689 xenotransplantation Methods 0.000 title 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 102000008395 cell adhesion mediator activity proteins Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2836—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD106
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/80—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies
- C07K2317/81—Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies functional in the endoplasmatic reticulum [ER] or the Golgi apparatus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Control Of High-Frequency Heating Circuits (AREA)
- Processes For Solid Components From Exhaust (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9825555.7A GB9825555D0 (en) | 1998-11-20 | 1998-11-20 | Suppression of xenotransplant rejection |
PCT/GB1999/003888 WO2000031126A2 (en) | 1998-11-20 | 1999-11-22 | Suppression of xenotransplant rejection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE269896T1 true ATE269896T1 (de) | 2004-07-15 |
Family
ID=10842836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99956179T ATE269896T1 (de) | 1998-11-20 | 1999-11-22 | Unterdrückung der abstossung bei xenotransplantation |
Country Status (9)
Country | Link |
---|---|
US (2) | US20050255550A1 (es) |
EP (1) | EP1131411B1 (es) |
JP (1) | JP2002531072A (es) |
AT (1) | ATE269896T1 (es) |
AU (1) | AU1282900A (es) |
DE (1) | DE69918327T2 (es) |
ES (1) | ES2224713T3 (es) |
GB (1) | GB9825555D0 (es) |
WO (1) | WO2000031126A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2559720A1 (en) | 2004-03-17 | 2005-09-29 | Revivicor, Inc. | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
ES2679282T3 (es) | 2004-10-22 | 2018-08-23 | Revivicor Inc. | Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena |
WO2008153725A2 (en) | 2007-05-25 | 2008-12-18 | North Carolina State University | Viral nanoparticle cell-targeted delivery platform |
CN103242444A (zh) | 2007-10-11 | 2013-08-14 | 大学健康网络 | 调节SIRPα-CD47相互作用以增加造血干细胞植入和用于此的化合物 |
DK2348827T3 (en) | 2008-10-27 | 2015-07-20 | Revivicor Inc | IMMUNICIPLY COMPROMATED PETS |
CA2757842A1 (en) * | 2009-04-09 | 2010-10-14 | The Children's Hospital Of Philadelphia | Ligand-specific inhibition of attachment of immune cells to implantable biomaterials |
CA2766634A1 (en) | 2009-06-22 | 2011-01-13 | Burnham Institute For Medical Research | Methods and compositions using peptides and proteins with c-terminal elements |
AU2012217792A1 (en) | 2011-02-14 | 2013-08-29 | Revivicor, Inc. | Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof |
WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
JP6025067B2 (ja) * | 2011-03-31 | 2016-11-16 | iHeart Japan株式会社 | 新規心筋細胞マーカー |
EP2715291A4 (en) | 2011-05-31 | 2015-10-21 | Airware Inc | NON-DISPERSIVE GAS SENSORS WITH ABSORPTION INFRARED ABSORPTION (NDIR) |
US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
EP3628047A1 (en) | 2017-05-02 | 2020-04-01 | Sanford Burnham Prebys Medical Discovery Institute | Tumor associated monocyte/macrophage binding peptide and methods of use thereof |
US20220119450A1 (en) | 2019-02-04 | 2022-04-21 | University Of Tartu | Bi-specific extracellular matrix binding peptides and methods of use thereof |
AU2021385081A1 (en) | 2020-11-20 | 2023-06-29 | Revivicor, Inc. | Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation |
EP4404740A1 (en) | 2021-09-20 | 2024-07-31 | Revivicor Inc. | Multitransgenic pigs comprising ten genetic modifications for xenotransplantation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2732546B2 (ja) * | 1992-09-02 | 1998-03-30 | アイシス・ファーマシューティカルス・インコーポレーテッド | 細胞接着のオリゴヌクレオチド調節 |
WO1996015780A1 (en) * | 1994-11-23 | 1996-05-30 | Isis Pharmaceuticals, Inc. | Compositions and methods for preventing and treating allograft rejection |
JP2002514895A (ja) * | 1995-09-28 | 2002-05-21 | アレクション、ファーマスーティカルズ、インコーポレーテッド | ブタ細胞相互作用タンパク質 |
FR2751346A1 (fr) * | 1996-07-19 | 1998-01-23 | Inst Nat Sante Rech Med | Procede de preparation d'organes de mammiferes non humains transgeniques en vue de leur transplantation chez l'homme, et sequences nucleotidiques pour la mise en oeuvre de ce procede |
-
1998
- 1998-11-20 GB GBGB9825555.7A patent/GB9825555D0/en not_active Ceased
-
1999
- 1999-11-22 ES ES99956179T patent/ES2224713T3/es not_active Expired - Lifetime
- 1999-11-22 JP JP2000583953A patent/JP2002531072A/ja active Pending
- 1999-11-22 AU AU12829/00A patent/AU1282900A/en not_active Abandoned
- 1999-11-22 EP EP99956179A patent/EP1131411B1/en not_active Expired - Lifetime
- 1999-11-22 WO PCT/GB1999/003888 patent/WO2000031126A2/en active IP Right Grant
- 1999-11-22 AT AT99956179T patent/ATE269896T1/de not_active IP Right Cessation
- 1999-11-22 DE DE69918327T patent/DE69918327T2/de not_active Expired - Fee Related
-
2004
- 2004-12-20 US US11/018,106 patent/US20050255550A1/en not_active Abandoned
-
2006
- 2006-12-08 US US11/635,968 patent/US20070157328A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002531072A (ja) | 2002-09-24 |
WO2000031126A3 (en) | 2000-08-24 |
AU1282900A (en) | 2000-06-13 |
US20070157328A1 (en) | 2007-07-05 |
DE69918327T2 (de) | 2006-05-11 |
GB9825555D0 (en) | 1999-01-13 |
WO2000031126A2 (en) | 2000-06-02 |
US20050255550A1 (en) | 2005-11-17 |
EP1131411B1 (en) | 2004-06-23 |
ES2224713T3 (es) | 2005-03-01 |
DE69918327D1 (de) | 2004-07-29 |
EP1131411A2 (en) | 2001-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE269896T1 (de) | Unterdrückung der abstossung bei xenotransplantation | |
DE69937888D1 (de) | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen | |
DE60032789D1 (de) | Mikrostruktur-stentstruktur | |
WO2006124365A3 (en) | Endothelial cell binding coatings for rapid encapsulation of bioerodable stents | |
WO2001077299A3 (en) | A METHOD TO PREVENT GRAFT REJECTION USING TGF-β TO INDUCE T SUPPRESSOR CELLS | |
DE60045230D1 (de) | Eingangs/Ausgangszellenanordnung für mehrere Eingangs/Ausgangsstandards | |
WO2002060894A3 (en) | Sulfonamide lactam inhibitors of factor xa | |
DE60032102D1 (de) | Beschichtung für einen stent | |
DE69922976D1 (de) | Austragungsvorrichtung für implantierbare stents | |
DK1207904T3 (da) | Nye kliniske parametre til bestemmelse af hæmatologisk toksicitet forud for radioimmunterapi | |
ZA985247B (en) | Guanidine mimics as factor Xa inhibitors. | |
MA30415B1 (fr) | Pale de rotor pour centrale electrique eolienne | |
DE59814262D1 (de) | Wandler für teil- oder vollimplantierbare Hörgeräte | |
DE59814473D1 (de) | Wandleranordnung für teil- oder vollimplantierbare Hörgeräte | |
DK1773420T3 (da) | Anvendelse af gingivale fibroblaster til vaskulær celleterapi | |
TR200101704T2 (tr) | Transplant reddinin engellenmesi için bir MEK inhibitörünün kullanımı | |
TR200003323T2 (tr) | Geniş-tesir sahalı mantar önleyiciler olarak suda eriyebilir azoller | |
DE69917554D1 (de) | Kathodisches Aktivmaterial für Lithium-Akkumulator | |
ATE410707T1 (de) | Kovalent gebundene, hydrophile beschichtungszusammensetzungen für implantate | |
WO2004044127A3 (en) | Stem cell populations | |
HK1060855A1 (en) | Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function | |
EA200300468A1 (ru) | Подавление зависимости опухолевых клеток от фактора роста | |
ATE248709T1 (de) | Verbundelemente | |
DE60023034D1 (en) | Cd45 hemmer | |
MXPA03001986A (es) | Composiciones antitromboticas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1131411 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |